University of Illinois at Chicago - College of Medicine

Dr. Julie Rowin is an Associate Professor in the Department of Neurology and Rehabilitation at the University of Illinois at Chicago College of Medicine and Director of the Electromyography Laboratory and Director of the MDA and ALS clinics at the University of Illinois at Chicago.

Dr Rowin received her medical degree from Northwestern University in 1993. She Completed her Neurology Residency and Fellowship in EMG and Neuromuscular Disease at Rush University Medical Center in Chicago in 1998.

Dr. Rowin is certified in Neurology, Neuromuscular Medicine and Clinical Neurophysiology by the American Board of Psychiatry and Neurology, and she is certified in Electromyography by the American Board of Electrodiagnostic Medicine.

Dr. Rowin’s research interests include myasthenia gravis and ALS or Lou Gherig’s Disease.
Ongoing research studies/grants:
Rowin J (Site PI), Meriggioli M (Co-Site PI). Genome Wide
Association Study in Myasthenia Gravis. PI: Daniel Drachman MD. Sponsor:
Myasthenia Gravis Foundation of America.

- Meriggioli MN (PI), Rowin J (Co-I), Jianrong Sheng, PhD, Bellur
Prabhakar, PhD. Regulatory T Cells in the Pathogenesis of Human Myasthenia
Gravis.

- Little D (PI), Rowin J (Co-I), Meriggioli M, Kincaid O. Magnetic
Resonance Imaging in amyotrophic lateral sclerosis.

-Rowin J (PI). Enteral nutrition in ALS patients with Ventilatory
Failure: minimizing the work of breathing. Sponsor: ALS Association

Gordon PH, Cheung YK, Levin B, Andrews H, Doorish C, Macarthur RB, Montes J, Bednarz K, Florence J, Rowin J, Boylan K, Mozaffar T, Tandan R, Mitsumoto H, Kelvin EA, Chapin J, Bedlack R, Rivner M, McCluskey LF, Pestronk A, Graves M, Sorenson EJ, Barohn RJ, Belsh JM, Lou JS, Levine T, Saperstein D, Miller RG, Scelsa SN; Combination Drug Selection Trial Study Group. A novel, efficient, randomized selection trial comparing combinations of drug therapy for ALS. Amyotroph Lateral Scler. 2008 Aug;9(4):212-22

Rowin J. Etanercept treatment in myasthenia Gravis. Ann NY Acad Sci 2008;1132:300-4.

Rowin J, Cheng G, Lewis SL, Meriggioli MN. Late appearance of dropped head syndrome after radiotherapy for Hodgkin's disease. Muscle Nerve 2006;34(5):666-669.

Rowin J, Amato AA, Deisher N, Cursio J, Meriggioli MN. Mycophenolate mofetil in dermatomyositis: is it safe? Neurology 2006;66:1245-1247.

Rowin J, Lewis SL. Copper deficiency myeloneuropathy with pancytopenia secondary to overuse of zinc. J Neurol Neurosurg Psychiatry 2005 May;76(5):750-1

Recent Peer Reviewed Publications:

- Lou JS, Moore D, Gordon PH, and Miller R for the* Minocycline Study Group*. Correlates of quality of life in ALS: Lessons learned from the minocycline study.* Amyotrophic lateral Sclerosis* 2009; 1471-180X.

- Wolfe GI, Barohn R, Sanders D, and the* Muscle Study Group. * Comparisonof Outcome Measures from a Trial of Mycophenolate Mofetil in Myasthenia Gravis.* Muscle Nerve* 2008;38(5):1429-1433.

- Burns TM, Conaway MR, Cutter GR, Sanders DB;* Muscle Study Group*. Less is more, or almost as much: a 15-item quality-of-life instrument for myasthenia gravis.* Muscle Nerve* 2008 Aug;38(2):957-63.

- *The Muscle Study Group. * A trial of mycophenolate mofetil with prednisone as initial immunotherapy in myasthenia gravis. *Neurology*2008;71:394-399.

- Mullins L, Carpentier M, Paul R, Sanders D and the* Muscle Study Group.* A Disease-Specific Measure of Quality of Life for Myasthenia Gravis.* Muscle Nerve* 2008;38(2):947-56.**

- Gordon P, Cheung Y, Levin B, Andrews H, Doorish C, Macarthur B, Montes J, Bednarz K, Florence J,* Rowin J,* Boylan B, Mozaffar T, Tandan, R, Mitsumoto H, Kelvin E, Chapin J, Bedlack D, Rivner M, McCluskeyL, Pestronk A, Graves M, Sorenson E, Barohn R, Belsh J, Lou J, Levine T, Saperstein D, Miller R, Scelsa S, and the Combination Drug Selection Trial Study Group. A Novel, Efficient, Randomized Selection Trial Comparing Combinations of Drug Therapy for ALS.* Amyotrophic Lateral Sclerosis. ALS* 2008;9(4) 254-6.

- *Rowin J.* Etanercept treatment in myasthenia Gravis. * Ann NY Acad Sci* 2008;1132:300-4.**

- *Rowin J*, Cheng G, Lewis SL, Meriggioli MN. Late appearance of dropped head syndrome after radiotherapy for Hodgkin's disease.* Muscle Nerve* 2006;34(5):666-669.

- Kincaid O*, Rowin J.* Intracranial hypertension causing polyradiculopathy with prolonged or absent F-waves*. J Neurol Neurosurg Psychiatry* 2006;77(12):1384-1386*.*****

- *Rowin J,* Amato AA, Deisher N, Cursio J, Meriggioli MN. Mycophenolate mofetil in dermatomyositis: is it safe?* Neurology* 2006;66:1245-1247.

- Tüzün E, Saini SS, Ghosh S,* Rowin J,* Meriggioli MN, Premkumar C. Predictive value of serum anti-C1q antibody levels in experimental autoimmune myasthenia gravis.* Neuromuscul Disord* 2006;16(2):137-143.

- Tüzün E,. Meriggioli MN,* Rowin J*, Yuan H and Premkumar C. Myasthenia gravis patients with low plasma IL-6 and IFN-γ benefit frometanercept treatment*. J Autoimmunity* 2005;24:261-268.*

- *Rowin J,* Lewis SL. Copper deficiency myeloneuropathy with pancytopenia secondary to overuse of zinc.* J Neurol Neurosurg Psychiatry* 2005 May;76(5):750-1

Published Abstract

- *Rowin J,* Cursio J. Bolus Enteral Feedings May Increase the Work of Breathing in ALS Patients with Ventilatory Dysfunction.Presented at the 59 th Annual Meeting of the American Academy of Neurology,*Neurology* 2007;68(12) suppl 1:A28.

- *Rowin J*, Wilson R. A Cognitive Testing Battery with Binary Response Options to Minimize Response Demands in ALS Patients.16thInternational Symposium on ALS/MND in Dublin, 8-10, December 2005.

- Deisher N, Meriggioli MN,* Rowin J*. Mycophenolate Mofetil as a Steroid Sparing Agent for the Muscle Manifestations of Idiopathic Dermatomyositis. * Neurology* 2005;64(6) suppl 1:A290.

Book Chapters:

- *Rowin J.* The Rationale for Tumor Necrosis Antagonism (Etanercept) in the Treatment of Autoimmune Myasthenia Gravis. In: Myasthenia Gravis: Disease Mechanism  and Immune Intervention. Christadoss, Peditor). Linus Publishing, Inc*. (In press).*

- *Rowin J*, Meriggioli MN: Proprioception, Touch, and Vibratory Sensation. In: Textbook of Clinical Neurology, 2nd edition. Goetz CG and Pappert EJ (editors). Philadelphia, WB Saunders, 2006, pp. 315-349.

Invited Reviews (Peer Reviewed)

- *Rowin J. * Approach to the Patient with Suspected Myasthenia Gravis or ALS: A Clinician’s Guide. In:* American Academy of Neurology Continuum Series*, Myasthenic Disorders and ALS, Feb 2009, pp.13-34.